Rohto Pharmaceutical Co.,Ltd. (4527)

Name: Rohto Pharmaceutical Co.,Ltd. (4527) — historial de estados financieros
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Historial de ingresos, beneficios y flujo de caja según los estados financieros oficiales.

Consumer Defensive · Wall Street (EE. UU.) · Última actualización: 2026-10-02

Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods Japan, China, and internationally. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams.

Cifras clave

Capitalización bursátil: JPY 629 billion
Ingresos (ejercicio cerrado en 2026-03-31): JPY 343.7B
Beneficio neto: JPY 34.2B
Margen bruto: 56.1%
Margen neto: 10.0%

Ver gráficos interactivos y estados completos → Modelo de valoración (DCF) →

Cuenta de resultados anual

Cuenta de resultados	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Ingresos totales	JPY 343.7B	JPY 308.6B	JPY 270.8B	JPY 238.7B	—
Beneficio bruto	JPY 192.7B	JPY 174.4B	JPY 157.3B	JPY 137.4B	—
Ingresos operativos (EBIT)	JPY 41.1B	JPY 38.2B	JPY 40.1B	JPY 34.0B	—
Ingresos netos	JPY 34.2B	JPY 30.8B	JPY 30.9B	JPY 26.4B	—

Fuente: informes públicos de la empresa (SEC). Verifique en SEC EDGAR antes de confiar en cualquier cifra.

Balances, flujos de caja, datos trimestrales y ratios completos en el visor interactivo de 4527. /companies/us/4527

Empresas similares

La información de este sitio es solo educativa e informativa; no constituye asesoramiento de inversión. No se publican precios objetivo ni recomendaciones.

English version →Todas las acciones

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.